Engineering growth factor ligands and receptors for therapeutic innovation
Trends in Cancer · 2024-12 · 10 (12) · 1131-1146
DOI: 10.1016/j.trecan.2024.09.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2024-12. Verfasst von Xinran An und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA; Translational Tissue Engineering Center, Johns Hop…. Hauptthemen laut MEDLINE: Neoplasms, Protein Engineering. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, Emerson Collective LLC, National Institutes of Health.
Abstract (Originalsprache)
Growth factors signal through engagement and activation of their respective cell surface receptors to choreograph an array of cellular functions, including proliferation, growth, repair, migration, differentiation, and survival. Because of their vital role in determining cell fate and maintaining homeostasis, dysregulation of growth factor pathways leads to the development and/or progression of disease, particularly in the context of cancer. Exciting advances in protein engineering technologies have enabled innovative strategies to redesign naturally occurring growth factor ligands and receptors as targeted therapeutics. We review growth factor protein engineering efforts, including affinity modulation, molecular fusion, the design of decoy receptors, dual specificity constructs, and vaccines. Collectively, these approaches are catapulting next-generation drugs to treat cancer and a host of other conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of…
Förderung
- NEI NIH HHS
- Emerson Collective LLC
- National Institutes of Health
Zitieren
APA
An, X., Paoloni, J., Oh, Y., & Spangler, J. B. (2024). Engineering growth factor ligands and receptors for therapeutic innovation. Trends in Cancer, 10(12), 1131-1146. https://doi.org/10.1016/j.trecan.2024.09.006
Vancouver
An X, Paoloni J, Oh Y, Spangler JB. Engineering growth factor ligands and receptors for therapeutic innovation. Trends in Cancer. 2024;10(12):1131-1146. doi:10.1016/j.trecan.2024.09.006
BibTeX
@article{An2024,
author = {An, Xinran and Paoloni, Justin and Oh, Yuseong and Spangler, Jamie B},
title = {Engineering growth factor ligands and receptors for therapeutic innovation},
journal = {Trends in Cancer},
year = {2024},
volume = {10},
number = {12},
pages = {1131--1146},
doi = {10.1016/j.trecan.2024.09.006}
}
EUVIMED